8-K: Wiley Reports Q3 2025 Results, Driven by Research Growth and AI Licensing

Sentiment:

Quarterly Report


Wiley's Q3 2025 results show revenue growth in Research and AI licensing, leading to improved profitability and reaffirmed fiscal year outlook.

Better than expectedThe company's adjusted EPS and EBITDA margin are trending towards the higher end of the previously announced guidance.

Summary

  • Wiley reported its Q3 fiscal year 2025 results, with revenue at $405 million.
  • Adjusted revenue, excluding divestitures, increased by 1.2% at constant currency, driven by a 5.2% increase in Research revenue.
  • Operating income was $52 million, a significant improvement from the prior year's loss of $46 million.
  • Adjusted operating income increased by 27%, with a margin increase of 280 basis points.
  • EPS improved to a loss of $0.43, up $1.65, while adjusted EPS increased by 39%.
  • Year-to-date, adjusted revenue grew by 3.5% at constant currency, and adjusted operating income increased by 38% with a margin increase of 330 basis points.
  • The company reaffirmed its fiscal 2025 outlook, expecting revenue growth of approximately 3% and free cash flow of approximately $125 million.
  • Wiley is raising its fiscal 2026 adjusted EBITDA margin target to 25%+

Sentiment

Score: 8

Explanation: The document presents a positive outlook with strong growth in key areas like Research and AI licensing, improved profitability, and reaffirmed financial guidance. The company is also raising its Fiscal 2026 margin target, indicating confidence in future performance.

Positives

  • Research revenue showed strong growth, driven by open access, solutions, and AI licensing.
  • The company secured significant recurring revenue agreements in India and Brazil, expanding access to numerous institutions.
  • Wiley expanded a content licensing project for AI training, valued at $9 million.
  • Adjusted EBITDA margins improved in both Research and Learning segments.
  • Wiley is reaffirming its Fiscal 2025 growth outlook in the mid-to-high end of its ranges.
  • Wiley is raising its Fiscal 2026 margin target to 25%+

Negatives

  • Reported revenue decreased due to foregone revenue from divested businesses.
  • Learning revenue was down 6% as reported and at constant currency, impacted by a licensing renewal in the prior year and softness in Academic.
  • GAAP EPS was a loss of ($0.43) compared to a loss of ($2.08) in the prior year period.
  • Free Cash Flow was up $44 million to a use of $1 million, driven by improved operating performance, lower capex, and the timing of working capital.

Risks

  • The company's performance is subject to various factors, including investment in new technologies, subscriber renewal rates, economic conditions, and the ability to protect intellectual property.
  • Cyber risks and the failure to maintain the integrity of operational or security systems could negatively impact results.
  • The company's ability to leverage artificial intelligence technologies in its products and services is crucial for future success.
  • The company may never realize the full carrying value of goodwill and other identifiable intangible assets.

Future Outlook

Wiley reaffirms its Fiscal 2025 outlook, expecting revenue growth of approximately 3%, adjusted EBITDA margin at the high end of the 23-24% range, and free cash flow of approximately $125 million. The company is raising its Fiscal 2026 margin target to 25%+

Management Comments

  • Matthew Kissner, Wiley President and CEO, stated that the company continues to deliver disciplined growth and material margin expansion.
  • He highlighted the resilience of the Research business and the increasing demand for Wiley's content and data-driven insights for AI enablement.

Industry Context

Wiley's focus on research and learning aligns with the increasing global R&D spending and the growing demand for scientific content for AI model development. The company's recurring revenue model and strong market position in research publishing provide a competitive advantage.

Comparison to Industry Standards

  • Wiley's Research business competes with other major academic publishers such as Elsevier, Springer Nature, and Taylor & Francis.
  • Wiley's adjusted EBITDA margin of 23.2% for Q3 2025 is comparable to industry peers, but the company aims to improve this further with its Fiscal 2026 target of 25%+
  • The company's focus on AI licensing and partnerships mirrors a broader trend in the industry, with publishers seeking to leverage their content for AI applications.

Stakeholder Impact

  • Shareholders can expect continued returns through dividends and share repurchases.
  • Employees may benefit from the company's growth and strategic initiatives.
  • Researchers and institutions will gain access to expanded content and resources.
  • Customers can expect continued innovation and development of new products and services.

Next Steps

  • Wiley will continue to focus on driving growth in its Research business and leveraging its content for AI applications.
  • The company will disclose its full guidance for Fiscal 2026 in June 2025.
  • Wiley will conduct a conference call with investors to discuss the earnings release.

Key Dates

DateDescription
May 31, 2023Completed the sale of Tuition Manager.
January 1, 2024Completed the sale of University Services.
May 31, 2024Completed the sale of Wiley Edge, with the exception of its India operations.
August 31, 2024Completed the sale of Wiley Edge India operations and CrossKnowledge.
March 6, 2025Date of the earnings release and conference call for Q3 fiscal year 2025.
June 2025Wiley will disclose its full guidance for Fiscal 2026.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.